We are live on ! Find out more
OCA

OpenArc Corporate Advisory Portfolio holdings

AUM $8.41B
This Fund
S&P 500
This Quarter Est. Return
+16.96%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.41B
AUM Growth
+$1.42B
Cap. Flow
+$539M
Cap. Flow %
6.42%
Top 10 Hldgs %
33.46%
Holding
833
New
117
Increased
380
Reduced
255
Closed
44
Avg Time Held
1.6 quarters
Top 10 Avg Time Held
1.6 quarters
Top 20 Avg Time Held
1.7 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.82%
2 Technology 16.24%
3 Consumer Discretionary 5.63%
4 Healthcare 3.98%
5 Industrials 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GEHC icon
626
GE HealthCare
GEHC
$30.6B
$302K ﹤0.01%
4,711
+561
+14% +$36.9K
2025 Q4
2 quarters
ONC icon
627
BeOne Medicines Ltd
ONC
$39.6B
$301K ﹤0.01%
1,056
+267
+34% +$78.7K
2026 Q1
1 quarter
SNN icon
628
Smith & Nephew
SNN
$11.6B
$300K ﹤0.01%
+10,417
New +$324K
2026 Q2
0 quarters
IDXX icon
629
Idexx Laboratories
IDXX
$41.3B
$300K ﹤0.01%
570
+113
+25% +$63.4K
2025 Q4
2 quarters
COWZ icon
630
Pacer US Cash Cows 100 ETF
COWZ
$19B
$300K ﹤0.01%
4,823
-31
-0.6% -$1.96K
2025 Q4
2 quarters
WCC icon
631
WESCO International
WCC
$17.6B
$300K ﹤0.01%
868
-112
-11% -$38K
2026 Q1
1 quarter
HLN icon
632
Haleon
HLN
$41.8B
$299K ﹤0.01%
32,099
+912
+3% +$8.48K
2025 Q4
2 quarters
MOG.A icon
633
Moog Inc Class A
MOG.A
$11.8B
$299K ﹤0.01%
+706
New +$241K
2026 Q2
0 quarters
BOTZ icon
634
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.29B
$294K ﹤0.01%
7,747
– –
2025 Q4
2 quarters
EXPD icon
635
Expeditors International
EXPD
$25.1B
$294K ﹤0.01%
1,803
+271
+18% +$41.9K
2025 Q4
2 quarters
ATLC icon
636
Atlanticus Holdings
ATLC
$1.44B
$293K ﹤0.01%
2,868
-8,500
-75% -$689K
2025 Q4
2 quarters
FLR icon
637
Fluor
FLR
$6.65B
$291K ﹤0.01%
5,561
-4
-0.1% -$196
2025 Q4
2 quarters
XLB icon
638
State Street Materials Select Sector SPDR ETF
XLB
$7.82B
$291K ﹤0.01%
5,721
-286
-5% -$14.7K
2025 Q4
2 quarters
LEU icon
639
Centrus Energy
LEU
$2.77B
$290K ﹤0.01%
1,730
-552
-24% -$103K
2026 Q1
1 quarter
DOC icon
640
Healthpeak Properties
DOC
$13.1B
$289K ﹤0.01%
13,511
+3,410
+34% +$63.6K
2026 Q1
1 quarter
SLB icon
641
SLB Ltd
SLB
$72.4B
$288K ﹤0.01%
6,188
+790
+15% +$42.3K
2025 Q4
2 quarters
SHW icon
642
Sherwin-Williams
SHW
$77.7B
$285K ﹤0.01%
828
+145
+21% +$46.3K
2026 Q1
1 quarter
EMQQ icon
643
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$240M
$284K ﹤0.01%
9,090
– –
2025 Q4
2 quarters
PD icon
644
PagerDuty
PD
$1.28B
$283K ﹤0.01%
29,324
+120
+0.4% +$908
2025 Q4
2 quarters
EWJ icon
645
iShares MSCI Japan ETF
EWJ
$23.7B
$283K ﹤0.01%
3,033
+18
+0.6% +$1.63K
2025 Q4
2 quarters
ST icon
646
Sensata Technologies
ST
$6.13B
$283K ﹤0.01%
+5,921
New +$268K
2026 Q2
0 quarters
EBAY icon
647
eBay
EBAY
$51B
$282K ﹤0.01%
+2,522
New +$269K
2026 Q2
0 quarters
FORM icon
648
FormFactor
FORM
$10.2B
$279K ﹤0.01%
+1,745
New +$232K
2026 Q2
0 quarters
RPRX icon
649
Royalty Pharma
RPRX
$25.7B
$279K ﹤0.01%
4,974
+213
+4% +$11.1K
2026 Q1
1 quarter
POWR icon
650
iShares U.S. Power Infrastructure ETF
POWR
$449M
$278K ﹤0.01%
+9,945
New +$272K
2026 Q2
0 quarters

Similar funds

OpenArc Corporate Advisory's Q2 2026 Portfolio in Review

As of Q2 2026, OpenArc Corporate Advisory held 833 positions worth $8.41B, up 20% from $6.98B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

OpenArc Corporate Advisory deployed $539M of net new capital in Q2 2026, opening 117 new positions and adding to 380 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 437,245 shares worth $179M.

By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 57% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was iShares A.I. Innovation and Tech Active ETF, an estimated $119M trimmed.

  • OpenArc Corporate Advisory's largest Q2 2026 buy was iShares Russell 1000 ETF: 437,245 shares worth $179M.
  • OpenArc Corporate Advisory added most to Vanguard Russell 1000 Value ETF in Q2 2026, an estimated $55.3M increase.
  • OpenArc Corporate Advisory's biggest Q2 2026 reduction was iShares A.I. Innovation and Tech Active ETF, cutting an estimated $119M.
  • OpenArc Corporate Advisory fully exited Kiniksa Pharmaceuticals in Q2 2026, selling an estimated $2.33M.
  • OpenArc Corporate Advisory's ten largest holdings make up 33% of its $8.41B portfolio in Q2 2026.
  • OpenArc Corporate Advisory opened 117 new positions and closed 44 in Q2 2026.
  • OpenArc Corporate Advisory's portfolio value rose 20% quarter-over-quarter to $8.41B.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.